The IDH mutant gliomas (patient-derived glioma stem-like cells and human oligodendroglioma cell line grown in vitro and in xenografts) were also shown as being specifically sensitive to GLS inhibition by CB-839. Here, IDH1 is linked to oligodendroglioma.